Trial Profile
A single center, randomized trial to evaluate the effects of Diovan [valsartan] to maintain sinus rhythm in patients with persistent atrial fibrillation
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2015
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms DRAFT
- 14 Dec 2006 New trial record.